Search results
Roche looking to sell or shut down California biologic drug plant
Reuters via Yahoo Finance· 1 year agoSwiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in...
Roche diagnostics head to take helm of Swiss pharma giant
Reuters via Yahoo Finance· 2 years ago(Reuters) -Roche's head of diagnostics, Thomas Schinecker, is to take over as group chief executive...
Are Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?
Investor's Business Daily· 2 months agoRegeneron stock toppled Thursday after the Department of Justice filed a lawsuit saying the...
Roche shuffles early stage pipeline as it joins obesity rush
BioPharma Dive via Yahoo Finance· 4 months agoRoche is reshaping its early-stage pipeline of experimental drugs, jettisoning eight drug candidates...
US sues Regeneron, alleging false price reporting on Eylea
BioPharma Dive via Yahoo Finance· 2 months agoThe lawsuit claims the drugmaker didn’t disclose reimbursement to drug distributors for credit card...
UPDATE 1-Roche looking to sell Vacaville, California plant
Reuters via Yahoo Finance· 1 year agoSwiss drugmaker Roche Holding AG plans to sell or close its drug manufacturing plant in Vacaville, California, or it will shut the factory down by 2029, according to e-mailed letters to the ...
Amgen (AMGN) Posts Positive Data from Soliris' Biosimilar Study
Zacks via Yahoo Finance· 2 years agoAmgen's (AMGN) phase III study evaluating ABP 959, a biosimilar candidate to Soliris for treating...
Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal
Reuters via Yahoo Finance· 8 months agoZURICH/FRANKFURT (Reuters) -Switzerland's Roche has agreed to pay an initial $7.1 billion to Roivant...
G1 Therapeutics to halt drug trial in colon cancer, shares plunge
Reuters via Yahoo News· 1 year ago(Reuters) -G1 Therapeutics Inc said on Monday it would terminate a late-stage study of its lead drug as it was unlikely to be effective in extending survival in patients with a type of colorectal ...
Here’s a Radical Tactic to Bypass UK Health Logjam: Look Abroad
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- Most Read from BloombergUBS to Buy Credit Suisse in $3.3 Billion Deal to End...
